Cbo & Sr Vp at Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Richard Thomas Kassberg, has recently reported selling 3,333 shares of common stock, at a price of $ 54.82 per share. Following this transaction, Mr. Kassberg directly holds 102,471 securities at this $ 1.83 Billion Market Cap Company. These sales were effected under a trading plan adopted by Mr. Kassberg, pursuant to Rule 10b5-1. This isn’t the first sell pursued by Mr. Kassberg over the course of this year. Cbo & Senior VP reported selling another 20,000 shares of this stock, at prices ranging from $ 55.00 to $ 52.82, during first quarter, 2014. Moreover, Mr. Kassberg also reported boosting 1,500 shares during that quarter, at a price of $ 21.00 per share.
Other important insiders have sold shares of this stock over the course of 2014. Cfo and Senior VP Shalini Sharp reported selling 4,000 shares, at a Price of $ 53.97 per share, during August, 2014, and Tpg Group Holdings (Sbs) Advisors, Inc. reported a sell of 488,820, during Q3, 2014, at an average Price of $ 37.60 per share.
In addition, hedge funds haven’t been currently active at this development-stage biopharmaceutical company.